Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Reexamination Certificate
2006-03-14
2006-03-14
Smith, Lynette R. F. (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
C424S178100, C424S184100, C424S200100, C424S234100, C424S250100, C424S278100, C424S282100, C435S041000, C435S243000, C435S235100, C435S252100, C530S388400
Reexamination Certificate
active
07011836
ABSTRACT:
It is possible to inactivate the early stage of lipid A synthesis of mucosal gram negative bacteria without compromising cell viability. In particular the lpxA gene inN. meningitidiswas mutated and resulting lpxA knockout mutants were found to be completely lipopolysaccharide (LPS)-deficient. The major outer membrane proteins (OMPs) were detected in normal amounts. The finding provides important implications for understanding of structure and biogenesis of the outer membrane. On a practical level, the availability of LPS-deficient mutants of pathogenic mucosal bacteria such asN. meningitidisopens up new avenues to vaccine development. It enables easy isolation of endotoxin-free purified proteins, outer membranes or even whole-cell preparations for use in immunisation.
REFERENCES:
patent: 5527529 (1996-06-01), Dougan et al.
patent: 624376 (1994-05-01), None
patent: 0 624 376 (1994-11-01), None
patent: WO 97/19688 (1997-06-01), None
patent: WO 97/25061 (1997-07-01), None
Galloway et al. 1990. 265(11):6394-6402.
Jennings et al. 1995. Microbial. Path. 19: 391-407.
Rick et al. 1977. J. of Biol. Chem. 14(25):4895-4903.
Servos et al. 1996. 175:137-145.
Verheul et al. 1993. Micro. Rev. 57(1):34-49.
Vuorio et al. 1995. FEMS Micro. Letters. 134:227-232.
Ellis, R. 1988. Plotkin & Mortimer Vaccines. Cphapter 29, pp. 568574.
Boselgo et al. 1991. Vaccines and Immunotheraphy. Chapter 17, pp. 211-233.
Weinberg et al. 1983. Infect. and Immun. 42(1):219-223.
Steeghs Liana Juliana Josephine Margriet
Van Der Ley Peter Andre
De Staat der Nederlanden, vertenwoordigd door de Minister van We
Hines Ja'Na
Smith Lynette R. F.
Young & Thompson
LandOfFree
Mutants of gram negative mucosal bacteria and application... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mutants of gram negative mucosal bacteria and application..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mutants of gram negative mucosal bacteria and application... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3589867